BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to AGS cell line is 73
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 1 | 33288885 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.52 | 1 | 31261030 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | Four-dimensional (4D) culture model by a magnetic responsive alginate-based hydrogel to rotating magnets followed by RT-PCR and IF staining | NA | 0.52 | 1 | 33836517 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qPCR and FACs | NA | 0.52 | 1 | 29559846 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.52 | 1 | 28461325 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.52 | 1 | 32606358 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.52 | 1 | 27735991 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.52 | 1 | 29512256 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.52 | 1 | 28822889 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by RT-PCR | NA | 0.52 | 1 | 32051395 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | FACs | NA | 0.52 | 1 | 30485589 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | Adriamycin | FACs | NA | 0.52 | 1 | 31261030 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by FACs | NA | 0.52 | 1 | 32707998 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | FACs | NA | 0.52 | 1 | 33273858 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | FACs followed by SFA | NA | 0.52 | 1 | 33061365 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 0.5695 | 33288885 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | qRT-PCR followed by Western Blotting | NA | 0.52 | 0.5695 | 32093282 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA and Western Blotting | NA | 0.52 | 0.5695 | 34278502 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.52 | 0.5695 | 28461325 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.52 | 0.5695 | 32606358 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.52 | 0.5695 | 35117718 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 29512256 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 32633423 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 34173116 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 28822889 |
| FZD7 | 4045 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.0064 | 29559846 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 31261030 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5461 | 28461325 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5461 | 32606358 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5461 | 33288885 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5461 | 35117718 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qPCR | NA | 0.48 | 0.5461 | 29559846 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.5461 | 29512256 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.5461 | 34173116 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 31261030 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA and Western Blotting | NA | 0.48 | 0.6448 | 34278502 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 28461325 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 32606358 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 33288885 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qPCR | NA | 0.48 | 0.6448 | 29559846 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 27735991 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 29512256 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 32633423 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 34173116 |
| PRKCD | 9399 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0032 | 31261030 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.7582 | 31261030 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | Four-dimensional (4D) culture model by a magnetic responsive alginate-based hydrogel to rotating magnets followed by RT-PCR and IF staining | NA | 0.48 | 0.7582 | 33836517 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.48 | 0.7582 | 28461325 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | Western Blotting and CFA | NA | 0.48 | 0.7582 | 31632151 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qPCR | NA | 0.48 | 0.7582 | 29559846 |
| ABCB1 | 40 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | Four-dimensional (4D) culture model by a magnetic responsive alginate-based hydrogel to rotating magnets followed by RT-PCR and IF staining | NA | 0.44 | 0.0604 | 33836517 |
| CD24 | 1645 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qPCR and FACs | NA | 0.32 | 0.456 | 29559846 |
| CD24 | 1645 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.32 | 0.456 | 28461325 |
| CD24 | 1645 | LTM | Gastric Cancer | Adenocarcinoma | AGS | Adriamycin | FACs | NA | 0.32 | 0.456 | 31261030 |
| CD24 | 1645 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by FACs | NA | 0.32 | 0.456 | 31261030 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.28 | 0.684 | 35117718 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by ALDEFLUOR assay | NA | 0.28 | 0.684 | 32707998 |
| KLF4 | 6348 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA and Western Blotting | NA | 0.28 | 0.0891 | 34278502 |
| KLF4 | 6348 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.0891 | 29512256 |
| KLF4 | 6348 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.0891 | 32633423 |
| KLF4 | 6348 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.0891 | 28822889 |
| MSI1 | 7330 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0201 | 28461325 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 28461325 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 32606358 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 33288885 |
| RAC1 | 9801 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0032 | 28461325 |
| SLC38A2 | 13448 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA and Western Blotting | NA | 0.28 | 0.0011 | 34173116 |
| TBL1XR1 | 29529 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0011 | 33288885 |
| GLI1 | 4317 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by IF staining | NA | 0.24 | 0.0308 | 33061365 |
| ABCG2 | 74 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qPCR | NA | 0.2 | 0.1739 | 29559846 |
| MIR193A | 31563 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | FACs for CSC marker followed by RT-PCR | NA | 0.2 | 0.0042 | 30485589 |
| MIR200C | 31580 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0074 | 32633423 |
| MIR520C | 32108 | LTM | Gastric Cancer | Adenocarcinoma | AGS | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0011 | 32633423 |